NeuPath Health Inc. (TSXV:NPTH)

Market Cap	31.91M +61.1%
Revenue (ttm)	88.97M +12.0%
Net Income	1.34M
EPS	0.02
Shares Out	56.98M
PE Ratio	24.43
Forward PE	6.32
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	0.5600
Day's Range	n/a
52-Week Range	0.3500 - 0.6800
Beta	0.83
Analysts	Buy
Price Target	0.82 (+45.54%)
Earnings Date	Nov 12, 2026

About NeuPath Health

NeuPath Health Inc. provides chronic pain management services in Canada. It operates a network of medical clinics in Ontario and Alberta that offer assessments and rehabilitation services to patients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions. The company also provides workplace health services and independent medical assessments to employers and disability insurers, as well as legal practices through a network of health care providers comprising cardiologists, dentists, dermatologists, psychiatri...

• Industry: Medical Care Facilities
• Sector: Healthcare
• CEO: Stephen Lemieux
• Employees: 152
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: NPTH

Financial Performance

In 2025, NeuPath Health's revenue was 87.19 million, an increase of 19.76% compared to the previous year's 72.81 million. Losses were -717,000, -1.51% less than in 2024.

Analyst Summary

According to 2 analysts, the average rating for NPTH stock is "Buy." The 12-month stock price target is $0.82, which is an increase of 45.54% from the latest price.

Price Target

$0.82

(45.54% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and QUODD

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by QUODD.

Last checked:

Nov 9, 2026

Data Sources Report a data error